Aviva PLC Axonics, Inc. Transaction History

Aviva PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$51.39 - $66.9 $1.12 Million - $1.46 Million	-21,788 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$49.14 - $59.89 $336,903 - $410,605	-6,856 Reduced 23.94%	21,788 $1.31 Million
Q4 2020 Feb 10, 2021	SELL	$42.19 - $51.5 $979,651 - $1.2 Million	-23,220 Reduced 44.77%	28,644 $1.43 Million
Q3 2020 Nov 12, 2020	SELL	$35.33 - $51.04 $506,490 - $731,709	-14,336 Reduced 21.66%	51,864 $2.65 Million
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $1.52 Million - $2.64 Million	66,200 New	66,200 $2.32 Million

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.